Skip to content

XACT ACE Observational Registry

Observational Post-Market Study of the XACT ACE Robotic System

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04950959
Enrollment
500
Registered
2021-07-06
Start date
2021-10-01
Completion date
2026-08-01
Last updated
2022-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tumors

Keywords

CT-guided percutaneous procedure, Percutaneous biopsy, XACT ACE Robotic System

Brief summary

Compile real world data on the use of the XACT ACE Robotic System

Detailed description

The purpose of this observational post-market study is to compile real world data on the use of the XACT ACE Robotic System in subjects undergoing CT guided, minimally invasive percutaneous procedures. The objectives are to 1) evaluate the proportion of procedures in which the instrument reached the pre-defined target, based on the physician's determination and CT imaging confirmation, 2) To evaluate system accuracy defined as the measured distance from the tip of the instrument to the target location at the at the end of the instrument insertion, and 3) Incidence of intra- and post-procedural adverse events. Up to 500 patients will be enrolled in this multicenter, nonrandomized, single arm registry.

Interventions

DEVICEHands-free, user-controlled robotic system intended to assist in the planning and advancement of an instrument during CT guided percutaneous procedures. T

The system is used for trajectory planning and is intended to assist the physician in the positioning of an instrument, such as a needle, where CT imaging is used for target trajectory planning and intraoperative tracking. The XACT ACE Robotic System uses a computerized quantitative guidance system, which provides real-time, accurate needle guidance, including advancement and steering of the needle from the entry point on the subject's body to the target point within the body.

Sponsors

Xact Robotics Ltd.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

1. ≥ 18 years of age 2. Subjects undergoing CT-guided, minimally invasive percutaneous procedures in the interventional radiology suite 3. Subject is willing to sign informed consent for the purposes of data collection

Exclusion criteria

1\. No

Design outcomes

Primary

MeasureTime frameDescription
Proportion of successful procedures1 hourTo evaluate the proportion of procedures in which the instrument reached the pre-defined target based on the physician's determination and CT imaging confirmation.
System accuracy1 hourTo evaluate system accuracy defined as the measured distance from the tip of the instrument to the target location at the end of the instrument insertion.
Assessment of Safety2 hours post-procedureIncidence of intra- and post-procedural events

Countries

United States

Contacts

Primary ContactMark Macedo
mark.macedo@xactrobotics.com5082076505

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026